Rhythm control agents and adverse events in patients with atrial fibrillation

International Journal of Clinical Practice

Volumn 64, Issue 8, 2010, Pages 1069-1075

  Taylor, C J ^a   Hodgkinson, J ^a   Hobbs, F D R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; FLECAINIDE; SOTALOL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DATA BASE; DRUG WITHDRAWAL; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LINKAGE ANALYSIS; LIVER FAILURE; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT DURATION; UNITED KINGDOM; VISUAL IMPAIRMENT;

ADULT; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; FEMALE; FLECAINIDE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SOTALOL;

EID: 77953835287     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02426.x     Document Type: Article

References (37)

1. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales. 1994-1998: analysis of data from the general practice research database. Heart 2001 86 : 284 288.
2. Wol PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991 22 : 983 988.
3. Wang TJ, Larson MG, Levy D et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003 107 : 2920 2925.
4. Miyasaka Y, Barnes ME, Bailey KR et al. Mortality trends in patients diagnosed with first atrial fibrillation - a 21-year community-based study. J Am Coll Cardiol 2007 49 : 986 992.
5. Aguilar MI, Hart R. Anti-platelet therapy for preventing stroke in patients with non-valvular atrial fibrillation with no previous history of stroke or transient ischaemic attacks. Cochrane Database Syst Rev 2005 : CD001925.
6. Aguilar MI, Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev. 2005 : CD001927.
7. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. NEJM 2002 347 : 1825 1833.
8. National Institute for Health and Clinical Excellence
9. Vaughan Williams EM. Classification of anti-arrhythmic drugs. In : Sandfte E, Flensted-Jensen E, Olesen KH, eds. Symposium on Cardiac Arrhythmia.
10. Roden DM. Electrophysiology: antiarrhytmic drugs: from mechanisms to clinical practice. Heart 2000 84 : 339 346.
11. Ashikaga K, Kobayashi T, Kimura M et al. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model. Eur J Pharmacol 2006 536 : 148 153.
12. Warrell DA, Cox TM, Firth JD, Benz EJ. Oxford Textbook of Medicine. Oxford University Press
13. Anderson JL, Prystowsky EN. Sotalol: an important new antiarrhythmic. Am Heart J 1999 137 : 388 409.
14. Rodriguez LAG, Gutthann SP. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998 45 : 419 425.
15. Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med 1994 121 : 529 535.
16. Schrickel JW, Schwab JO, Yang A. Pro-arrhythmic effects of amiodarone and concomitant rate-control medication. Europace 2006 8 : 403 407.
17. Essebag V, Hadjis T, Platt RW et al. Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction. J Am Coll Cardiol 2003 41 : 249 254.
18. Loh KC. Current concepts in medicine: amiodarone-induced thyroid disorders: a clinical review. Postgrad Med J 2000 76 : 133 140.
19. Martino E, Aghini-Lombardi F, Bartalena L et al. Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with autoimmune thyroid disease. Arch Intern Med 1994 23 : 2722 2726.
20. Batcher EL, Charlene Tang X, Singh BN et al. Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. Am J Med 2007 120 : 880 885.
21. Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med 1997 126 : 63 73.
22. Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 2007 298 : 1312 1322.
23. Puli SR, Fraley MA, Puli V. Hepatic cirrhosis caused by low-dose oral amiodarone therapy. Am J Med Sci 2005 330 : 257 261.
24. Martin WJ, Rosenow EC. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 1). Chest 1988 93 : 1067 1075.
25. Kaushik S, Hussain A, Clarke P. Acute pulmonary toxicity after low-dose amiodarone therapy. Ann Thorac Surg 2001 72 : 1760 1761.
26. Mantyjarvi M, Tuppurainen K, Ikaheimo K. Ocular side effects of amiodarone. Surv Ophthalmol 1998 42 : 360 366.
27. Shaikh S, Shaikh N, Chun SH et al. Retinal evaluation of patients on chronic amiodarone therapy. Retina 2003 23 : 354 359.
28. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. CAST and beyond. Implications of the cardiac arrhythmia suppression trial. Eur Heart J 1990 11 : 194 199.
29. Alboni P, Botto GL, Baldi N. Outpatient treatment of recent-onset atrial fibrillation with the 'Pill-in-the-Pocket' approach. N Engl J Med 2004 351 : 2384 2391.
30. Lafuente-Lafuente C, Mouly S, Longas-Tejero MA. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation. Arch Intern Med 2006 166 : 719 728.
31. Airaksinen KEJ, Koistinen MJ. ECG findings in fatal flecainide intoxication. Heart 2007 93 : 1499.
32. Brazil E, Bodiwala GG, Bouch DC. Fatal flecainide intoxication. J Accid Emerg Med 1998 15 : 423 425.
33. Singh BN, Singh SN, Reda DJ. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 2005 352 : 1861 1872.
34. Viskin S. Long QT syndromes and torsade de pointes. Lancet 1999 354 : 1625 1633.
35. The AFFIRM First Arrhythmic Drug Substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol 2003 42 : 20 9.
36. Humphries KH, Kerr CR, Steinbuch M et al. Limitations to antiarrhythmic drug use in patients with atrial fibrillation. CMAJ 2004 171 : 741 745.
37. Goldschlager N, Epstein AE, Naccarelli G et al. Practical guidelines for clinicians who treat patients with amiodarone. Arch Intern Med 2000 160 : 1741 1748.